NCT00664300

Brief Summary

Gilles de la Tourette's syndrome is a childhood onset inherited neuropsychiatric disorder characterised by the presence of both multiple motor tics and one or more vocal tics (noises), with psychiatric and/or behaviour disorders (such as obsessive compulsive behaviour…). This disease is associated with an dopamine system imbalance which could be responsible of a specific trouble in the recognition in some facial expression. This has been already shown in Gilles de la Tourette patients with obsessive compulsive behaviour. We hypothesise that patients with Gilles de la Tourette's syndrome present a dysfunction of voluntary and automatic treatment of emotional information. The main purpose of this study is to show if patients with Gilles de la Tourette's syndrome present a lack of specific facial expression recognition of emotion and determinate more precisely if this alteration involves the cortical way (high frequency way) or the under cortical way (low frequency way).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 22, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2008

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2009

Completed
Last Updated

January 19, 2011

Status Verified

January 1, 2011

Enrollment Period

1.2 years

First QC Date

April 21, 2008

Last Update Submit

January 18, 2011

Conditions

Keywords

Gilles de la Tourette's syndromeFacial expression recognition of emotionFrequency levelsAutomatic and voluntary information treatmentPatient with Gilles de la Tourette's syndrome

Outcome Measures

Primary Outcomes (1)

  • Facial expression recognition test

    % of exact responses

Secondary Outcomes (1)

  • Lexical decision test

    The time to respond

Study Arms (1)

2

One group with Gilles de la Tourette's Syndrome One group with healthy paired volunteers

Behavioral: Facial expression recognition of emotion

Interventions

Facial expression recognition test Lexical decision test

2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

30 patients with Gilles de la Tourette's Syndrome and 30 healthy paired volunteers (control group)

You may qualify if:

  • Age : \>18 years
  • Patient with a Gilles de la Tourette 's syndrome such as defined in the DSMIV
  • Stability of treatment \>1 month
  • Mini Mental State \> 26
  • Affiliation to social security
  • Agreement of patients

You may not qualify if:

  • Patients with cognitive disorders, dementia, mental retardation…
  • Patients with serious neurological pathologies
  • Patients with a vision contrast altered.
  • Patients who do not understand the words associated with an emotion
  • Pregnant women
  • Person who participate to an other study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU

Clermont-Ferrand, 63003, France

Location

MeSH Terms

Conditions

Tourette Syndrome

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTic DisordersMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental Disorders

Study Officials

  • Isabelle Jalenques, PUPH

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 21, 2008

First Posted

April 22, 2008

Study Start

August 1, 2007

Primary Completion

October 1, 2008

Study Completion

October 1, 2009

Last Updated

January 19, 2011

Record last verified: 2011-01

Locations